Phospholipase D2 antibody (N-Term)
Quick Overview for Phospholipase D2 antibody (N-Term) (ABIN927701)
Target
See all Phospholipase D2 (PLD2) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Cross-Reactivity
- Mouse (Murine), Cow (Bovine)
-
Purification
- Purified
-
Immunogen
- PLD2 antibody was raised in rabbit using the N terminal of PLD2 as the immunogen
-
-
-
-
Application Notes
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
PLD2 Blocking Peptide, (ABIN5615410), is also available for use as a blocking control in assays to test for specificity of this PLD2 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- Phospholipase D2 (PLD2)
-
Alternative Name
- PLD2
-
Background
- Phosphatidylcholine (PC)-specific phospholipases D (PLDs, EC 3.1.4.4) catalyze the hydrolysis of PC to produce phosphatidic acid and choline. Activation of PC-specific PLDs occurs as a consequence of agonist stimulation of both tyrosine kinase and G protein-coupled receptors. PC-specific PLDs have been proposed to function in regulated secretion, cytoskeletal reorganization, transcriptional regulation, and cell cycle control. Synonyms: Polyclonal PLD2 antibody, Anti-PLD2 antibody, phospholipase D2 antibody.
-
Pathways
- RTK Signaling, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Regulation of G-Protein Coupled Receptor Protein Signaling
Target
-